InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (22 ops.)
Insider track record
OtherDisclosed buys
0
Disclosed sells
22
T+90 hit rate
0%
T+90 mean return
-24.5%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Scalzo Richard William, Autre. Director active across 2 companies, notably Dyne Therapeutics, Inc.. Aggregated, 35 reports have been published. Split: 0 buy · 22 sells. Total volume traded: €625k. History available since 20 September 2021. The latest transaction was disclosed on 11 March 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations35 total
1,112 sharesOrdinary SharesSEC:0001628280-26-044890:0
1,343 shares@ US$11.381.3% of flowCommon StockSEC:0000950170-25-038731:0
917 shares@ US$11.831.0% of flowCommon StockSEC:0000950170-25-035490:0
2,488 shares@ US$13.953.1% of flowCommon StockSEC:0000950170-25-022455:0
1,455 shares@ US$28.123.7% of flowCommon StockSEC:0000950170-24-135570:0
32,700 shares0Common StockSEC:0000950170-24-134075:0
2,735 shares@ US$28.207.0% of flowCommon StockSEC:0000950170-24-127992:0
1,390 shares@ US$34.554.1% of flowCommon StockSEC:0000950170-24-108153:0
1,468 shares@ US$31.894.0% of flowCommon StockSEC:0000950170-24-105515:0
6,502 shares@ US$5.543.1% of flowCommon StockSEC:0000950170-24-105123:0
▼
2,442 shares@ US$45.019.4% of flowCommon StockSEC:0000950170-24-099128:0
1,590 shares@ US$30.234.2% of flowCommon StockSEC:0000950170-24-072140:0
2,126 shares@ US$28.205.2% of flowCommon StockSEC:0000950170-24-062077:0
◇
68,919 shares@ US$5.5433.2% of flowCommon StockSEC:0000950170-24-030482:0
2,273 shares@ US$25.855.1% of flowCommon StockSEC:0000950170-24-029603:0
3,429 shares@ US$1.030.3% of flowCommon StockSEC:0000950170-24-024298:0
13,000 shares@ US$1.031.2% of flowCommon StockSEC:0000950170-24-008061:0
13,000 shares@ US$1.031.2% of flowCommon StockSEC:0000950170-24-002277:0
2,376 shares@ US$12.022.5% of flowCommon StockSEC:0001209191-23-058666:0
1,380 shares@ US$10.721.3% of flowCommon StockSEC:0001209191-23-058332:0
681 shares@ US$12.010.7% of flowCommon StockSEC:0001209191-23-057671:0
89,742 shares0Common StockSEC:0001209191-23-055533:0
1,290 shares@ US$9.4113.0% of flowCommon StockSEC:0001209191-23-050174:0
1,397 shares@ US$10.411.3% of flowCommon StockSEC:0001209191-23-049361:0
1,390 shares@ US$12.431.5% of flowCommon StockSEC:0001209191-23-037487:0
25 of 35 declarations
About Scalzo Richard William
Richard William Scalzo is a key member of Dyne Therapeutics, Inc. Although his specific role is not detailed, he contributes to the company's mission through his expertise and guidance. His commitment to innovation and strategic development is essential for Dyne Therapeutics' success.
